These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 10815799)

  • 21. c-Src couples PI 3 kinase/Akt and MAPK signaling to PDGF-induced DNA synthesis in mesangial cells.
    Choudhury GG; Mahimainathan L; Das F; Venkatesan B; Ghosh-Choudhury N
    Cell Signal; 2006 Nov; 18(11):1854-64. PubMed ID: 16530387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.
    Vignais ML; Sadowski HB; Watling D; Rogers NC; Gilman M
    Mol Cell Biol; 1996 Apr; 16(4):1759-69. PubMed ID: 8657151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
    Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
    Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
    Karni R; Jove R; Levitzki A
    Oncogene; 1999 Aug; 18(33):4654-62. PubMed ID: 10467412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDGF-independent activation of PDGF-beta receptors in NIH-3T3 cells transformed by c-met protooncogene.
    Kochhar KS; Linnekin D; Iyer AP
    Exp Cell Res; 1994 Jun; 212(2):414-21. PubMed ID: 7514539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of JAK-STAT pathway is required for platelet-derived growth factor-induced proliferation of pancreatic stellate cells.
    Masamune A; Satoh M; Kikuta K; Suzuki N; Shimosegawa T
    World J Gastroenterol; 2005 Jun; 11(22):3385-91. PubMed ID: 15948243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p91 STAT1 activation in interleukin-3-stimulated primary acute myeloid leukemia cells.
    Aronica MG; Brizzi MF; Dentelli P; Rosso A; Yarden Y; Pegoraro L
    Oncogene; 1996 Sep; 13(5):1017-26. PubMed ID: 8806691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of Stat3 in v-Src-transformed fibroblasts requires cooperation of Jak1 kinase activity.
    Zhang Y; Turkson J; Carter-Su C; Smithgall T; Levitzki A; Kraker A; Krolewski JJ; Medveczky P; Jove R
    J Biol Chem; 2000 Aug; 275(32):24935-44. PubMed ID: 10823829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-beta1-induced degradation of activated Src tyrosine kinase in rat fibroblasts.
    Fukuda K; Kawata S; Tamura S; Matsuda Y; Inui Y; Igura T; Inoue S; Kudara T; Matsuzawa Y
    Oncogene; 1998 Jul; 16(26):3349-56. PubMed ID: 9692542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pool of ligand-bound platelet-derived growth factor beta-receptors remain activated and tyrosine phosphorylated after internalization.
    Sorkin A; Eriksson A; Heldin CH; Westermark B; Claesson-Welsh L
    J Cell Physiol; 1993 Aug; 156(2):373-82. PubMed ID: 7688373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand activation causes a phosphorylation-dependent change in platelet-derived growth factor receptor conformation.
    Keating MT; Escobedo JA; Fantl WJ; Williams LT
    Trans Assoc Am Physicians; 1988; 101():24-32. PubMed ID: 2480016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple roles for Src in a PDGF-stimulated cell.
    DeMali KA; Godwin SL; Soltoff SP; Kazlauskas A
    Exp Cell Res; 1999 Nov; 253(1):271-9. PubMed ID: 10579928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
    Benito M; Lorenzo M
    Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a Y559F mutant CSF-1 receptor in M1 myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation.
    Marks DC; Csar XF; Wilson NJ; Novak U; Ward AC; Kanagasundarum V; Hoffmann BW; Hamilton JA
    Mol Cell Biol Res Commun; 1999 May; 1(2):144-52. PubMed ID: 10356364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for activated p21 ras in inhibition/regulation of platelet-derived growth factor (PDGF) type-beta receptor activation.
    Zubiaur M; Forman LW; Stice LL; Faller DV
    Oncogene; 1996 Mar; 12(6):1213-22. PubMed ID: 8649823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation and association of Stat3 with Src in v-Src-transformed cell lines.
    Cao X; Tay A; Guy GR; Tan YH
    Mol Cell Biol; 1996 Apr; 16(4):1595-603. PubMed ID: 8657134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PDGF receptor phosphorylates Tyr 138 in the c-Src SH3 domain in vivo reducing peptide ligand binding.
    Broome MA; Hunter T
    Oncogene; 1997 Jan; 14(1):17-34. PubMed ID: 9010229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-alpha induction of STATs1, -3 DNA binding and growth arrest is independent of Lck and active mitogen-activated kinase in T cells.
    Lund TC; Medveczky MM; Medveczky PG
    Cell Immunol; 1999 Mar; 192(2):133-9. PubMed ID: 10087181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased mitogenicity of an alphabeta heterodimeric PDGF receptor complex correlates with lack of RasGAP binding.
    Ekman S; Thuresson ER; Heldin CH; Rönnstrand L
    Oncogene; 1999 Apr; 18(15):2481-8. PubMed ID: 10229199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic STAT proteins associate prior to activation.
    Haan S; Kortylewski M; Behrmann I; Müller-Esterl W; Heinrich PC; Schaper F
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):417-21. PubMed ID: 10642496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.